Skip to content
Riskpilot
← Back to search
Sign in
Get full access
IMMUNOR AS
AS
Active
Org 914405920
Gaustadalléen 21, 0349
Oslo
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2014 · 11 years old
0 employees
www.immunor.com
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
IMMUNOR AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
-0M
-1M
-1M
-1M
-1M
2020
0M
+100%
2021
0M
0%
2022
0M
0%
2023
-1M
-100%
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
305
0
0
0
Staff expenses
−137
−74
−13
−0
−0
EBITDA
−1 221
−262
−498
−172
−1 328
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−1 221
−262
−498
−172
−1 328
Net financials
0
39
−414
−245
−66
Profit before tax
−1 220
−223
−912
−418
−1 395
Tax
−0
−0
−0
−0
−0
Net profit
−1 220
−223
−912
−418
−1 395
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
280
177
44
53
404
Equity
−1 601
−1 824
−2 736
−3 127
−106
Long-term debt
1 102
1 752
2 205
2 470
350
Short-term debt
779
249
575
711
159
Total debt
1 881
2 001
2 780
3 181
510
Financial ratios
5-year trend
EBITDA margin
-132831600.0%
This company
15.8%
Market median
-840706429% vs market
2020
2024
Equity ratio
-26.2%
This company
38.2%
Market median
-169% vs market
2020
2024
Return on equity
-139473600.0%
This company
18.4%
Market median
-758008796% vs market
2020
2024
Net profit margin
-139473600.0%
This company
8.1%
Market median
-1721896396% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
4.81×
This company
0.62×
Market median
-676% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on IMMUNOR AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
